Search research articles
Contact Us
Filters
Showing results (711-720 of 777) with videos related to
Page
of 78
Sort By:
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
February 26, 2020
Microglial Depletion with CSF1R Inhibitor During Chronic Phase of Experimental Traumatic Brain Injury Reduces Neurodegeneration and Neurological Deficits
Rebecca J Henry, Rodney M Ritzel, James P Barrett, et al.
Plos Pathogens
|
July 18, 2014
BCKDH: the missing link in apicomplexan mitochondrial metabolism is required for full virulence of Toxoplasma gondii and Plasmodium berghei
Rebecca D Oppenheim, Darren J Creek, James I Macrae, et al.
Molecular Microbiology
|
August 1, 2013
The threonine degradation pathway of the Trypanosoma brucei procyclic form: the main carbon source for lipid biosynthesis is under metabolic control
Yoann Millerioux, Charles Ebikeme, Marc Biran, et al.
Antimicrobial Agents and Chemotherapy
|
February 22, 2018
Complex Interplay between Sphingolipid and Sterol Metabolism Revealed by Perturbations to the Leishmania Metabolome Caused by Miltefosine
Emily G Armitage, Amjed Q I Alqaisi, Joanna Godzien, et al.
Eukaryotic Cell
|
December 8, 2009
Multiple genetic mechanisms lead to loss of functional TbAT1 expression in drug-resistant trypanosomes
Mhairi L Stewart, Richard J S Burchmore, Caroline Clucas, et al.
Plos Neglected Tropical Diseases
|
May 15, 2018
Benzoxaborole treatment perturbs S-adenosyl-L-methionine metabolism in Trypanosoma brucei
Pieter C Steketee, Isabel M Vincent, Fiona Achcar, et al.
International Journal of Antimicrobial Agents
|
November 14, 2009
Antimicrobial treatment and clinical outcome for infections with carbapenem- and multiply-resistant Acinetobacter baumannii around London
David M Livermore, Robert L R Hill, Hazel Thomson, et al.
Eukaryotic Cell
|
October 14, 2003
Mechanisms of arsenical and diamidine uptake and resistance in Trypanosoma brucei
Enock Matovu, Mhairi L Stewart, Federico Geiser, et al.
Chemmedchem
|
August 7, 2012
Synthesis and biological evaluation of CTP synthetase inhibitors as potential agents for the treatment of African trypanosomiasis
Lucia Tamborini, Andrea Pinto, Terry K Smith, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
February 8, 2020
Interferon-β Plays a Detrimental Role in Experimental Traumatic Brain Injury by Enhancing Neuroinflammation That Drives Chronic Neurodegeneration
James P Barrett, Rebecca J Henry, Kari Ann Shirey, et al.
Page
of 78
Search research articles
Search
Showing results (711-720 of 777) with videos related to
Sort By:
Page
of 78
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
February 26, 2020
Microglial Depletion with CSF1R Inhibitor During Chronic Phase of Experimental Traumatic Brain Injury Reduces Neurodegeneration and Neurological Deficits
Rebecca J Henry, Rodney M Ritzel, James P Barrett, et al.
Plos Pathogens
|
July 18, 2014
BCKDH: the missing link in apicomplexan mitochondrial metabolism is required for full virulence of Toxoplasma gondii and Plasmodium berghei
Rebecca D Oppenheim, Darren J Creek, James I Macrae, et al.
Molecular Microbiology
|
August 1, 2013
The threonine degradation pathway of the Trypanosoma brucei procyclic form: the main carbon source for lipid biosynthesis is under metabolic control
Yoann Millerioux, Charles Ebikeme, Marc Biran, et al.
Antimicrobial Agents and Chemotherapy
|
February 22, 2018
Complex Interplay between Sphingolipid and Sterol Metabolism Revealed by Perturbations to the Leishmania Metabolome Caused by Miltefosine
Emily G Armitage, Amjed Q I Alqaisi, Joanna Godzien, et al.
Eukaryotic Cell
|
December 8, 2009
Multiple genetic mechanisms lead to loss of functional TbAT1 expression in drug-resistant trypanosomes
Mhairi L Stewart, Richard J S Burchmore, Caroline Clucas, et al.
Plos Neglected Tropical Diseases
|
May 15, 2018
Benzoxaborole treatment perturbs S-adenosyl-L-methionine metabolism in Trypanosoma brucei
Pieter C Steketee, Isabel M Vincent, Fiona Achcar, et al.
International Journal of Antimicrobial Agents
|
November 14, 2009
Antimicrobial treatment and clinical outcome for infections with carbapenem- and multiply-resistant Acinetobacter baumannii around London
David M Livermore, Robert L R Hill, Hazel Thomson, et al.
Eukaryotic Cell
|
October 14, 2003
Mechanisms of arsenical and diamidine uptake and resistance in Trypanosoma brucei
Enock Matovu, Mhairi L Stewart, Federico Geiser, et al.
Chemmedchem
|
August 7, 2012
Synthesis and biological evaluation of CTP synthetase inhibitors as potential agents for the treatment of African trypanosomiasis
Lucia Tamborini, Andrea Pinto, Terry K Smith, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
February 8, 2020
Interferon-β Plays a Detrimental Role in Experimental Traumatic Brain Injury by Enhancing Neuroinflammation That Drives Chronic Neurodegeneration
James P Barrett, Rebecca J Henry, Kari Ann Shirey, et al.
Page
of 78